Tectonic announced that company management will present at the 2024 Wells Fargo Healthcare Conference being held in Boston September 4-6, 2024 and will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference.
investors.tectonictx.com/new…
We are one week in as a Nasdaq listed company! Proud of this team working to advance our lead program to help patients with heart failure and pulmonary hypertension #Innovation
Exciting week here at Tectonic Therapeutic! As of June 21st, we will be listed on Nasdaq as “TECX” and you can find our company updates at tectonictx.combwnews.pr/3Xx4McQ
Tim Springer’s deep commitment to #science and understanding human disease is inspiring. We are honored to have him as a #founder. He is an incredible collaborator, philanthropist and scientist.
Harvard Medical School professor and entrepreneur Tim Springer has donated $210 million to the Institute for Protein Innovation, a Boston-based nonprofit research organization focused on protein science. trib.al/jYSKal0
To celebrate #EarthWeek the Tectonic Team spent yesterday afternoon cleaning up the Charles River land across from our office, admiring the beauty we are lucky enough to be surrounded by every day #LookAround#EarthDay#EarthDay2023
#10YearsLater we honor and remember those who risked their lives for the safety of our city and people #BostonStrong
Good luck to all of the runners running the 127th #BostonMarathon today!
Happy #EmployeeAppreciationDay! Today we are shining the spotlight on the winners of our #TectonicAwards for being valuable scientific and cultural contributors. Thank you for all you do Kristie Barth, Ashley Smith, Joana Khatib, Peter Marek, Sarah Nordeen and Victoria Jenny!
Congratulations to our co-founder @TimothySpringer on winning the 2022 #LaskerAward. A truly incredible achievement. We are so fortunate to have access to his knowledge and scientific insights. #Lasker2022#LaskerLaureate
Tomorrow, our CEO @AliseReicin will moderate the Oncology Panel, Moving Closer to Cure for More Cancer Patients at @USAIC 16th Annual BioPharma Summit. The panel is free to attend, tune in at 8:10 AM ET tomorrow.
This Wednesday at 12:00 PM ET, our CEO Alise Reicin, MD will serve as a panelist in an important discussion addressing imposter syndrome in biotech leadership. She will be joined by industry leaders as they discuss their experience and how to mitigate it. us02web.zoom.us/webinar/regi…
We’re delighted to welcome Hamida and Samantha as our interns from @HCCconnects, a national non-profit focused on inspiring and empowering the next generation of diverse, transformational health leaders.
Catch our CEO Alise Reicin, MD at the Endpoints News roundtable discussion about best practices in drug development this Thursday, April 28 at 2:00pm ET. You can register here: webinars.endpts.com/the-rd-c…